267 related articles for article (PubMed ID: 33263761)
21. Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes.
Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Nordberg A; Viitanen M; Lannfelt L; Graff C
Neurobiol Aging; 2019 Oct; 82():40-47. PubMed ID: 31386938
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease: A Single-Family Case-Control Study.
Day GS; Musiek ES; Roe CM; Norton J; Goate AM; Cruchaga C; Cairns NJ; Morris JC
JAMA Neurol; 2016 Sep; 73(9):1125-32. PubMed ID: 27454811
[TBL] [Abstract][Full Text] [Related]
23. Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred.
Fuller JT; Cronin-Golomb A; Gatchel JR; Norton DJ; Guzmán-Vélez E; Jacobs HIL; Hanseeuw B; Pardilla-Delgado E; Artola A; Baena A; Bocanegra Y; Kosik KS; Chen K; Tariot PN; Johnson K; Sperling RA; Reiman EM; Lopera F; Quiroz YT
J Prev Alzheimers Dis; 2019; 6(2):112-120. PubMed ID: 30756118
[TBL] [Abstract][Full Text] [Related]
24. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT
JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823
[TBL] [Abstract][Full Text] [Related]
25. Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease.
Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Amberla K; Axelman K; Basun H; Kinhult-Ståhlbom A; Lilius L; Remes A; Wahlund LO; Viitanen M; Lannfelt L; Graff C
J Int Neuropsychol Soc; 2017 Mar; 23(3):195-203. PubMed ID: 28079014
[TBL] [Abstract][Full Text] [Related]
26. Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial.
Rios-Romenets S; Lopera F; Sink KM; Hu N; Lian Q; Guthrie H; Smith J; Cho W; Mackey H; Langbaum JB; Thomas RG; Giraldo-Chica M; Tobon C; Acosta-Baena N; Muñoz C; Ospina P; Tirado V; Henao E; Bocanegra Y; Chen K; Su Y; Goradia D; Thiyyagura P; VanGilder PS; Luo J; Ghisays V; Lee W; Malek-Ahmadi MH; Protas HD; Chen Y; Quiroz YT; Reiman EM; Tariot PN;
Alzheimers Dement; 2020 Jul; 16(7):1023-1030. PubMed ID: 32418361
[TBL] [Abstract][Full Text] [Related]
27. Impaired Memory Awareness and Loss Integration in Self-Referential Network Across the Progression of Alzheimer's Disease Spectrum.
Chen S; Song Y; Xu W; Hu G; Ge H; Xue C; Gao J; Qi W; Lin X; Chen J;
J Alzheimers Dis; 2021; 83(1):111-126. PubMed ID: 34250942
[TBL] [Abstract][Full Text] [Related]
28. Subjective memory complaints in preclinical autosomal dominant Alzheimer disease.
Norton DJ; Amariglio R; Protas H; Chen K; Aguirre-Acevedo DC; Pulsifer B; Castrillon G; Tirado V; Munoz C; Tariot P; Langbaum JB; Reiman EM; Lopera F; Sperling RA; Quiroz YT
Neurology; 2017 Oct; 89(14):1464-1470. PubMed ID: 28878053
[TBL] [Abstract][Full Text] [Related]
29. Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers.
Guzmán-Vélez E; Martínez J; Papp K; Baena A; Vila-Castelar C; Artola A; Schultz AP; Bocanegra Y; Sanchez J; Rentz D; Tariot PN; Reiman EM; Sperling R; Johnson KA; Lopera F; Quiroz YT
Neurology; 2020 Sep; 95(10):e1312-e1321. PubMed ID: 32611637
[TBL] [Abstract][Full Text] [Related]
30. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.
Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Porter T; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Martins RN; Salvado O; Bourgeat P; Rowe CC; Masters CL; Maruff P
Neurology; 2016 Apr; 86(17):1635-42. PubMed ID: 27029632
[TBL] [Abstract][Full Text] [Related]
31. Can a failure in the error-monitoring system explain unawareness of memory deficits in Alzheimer's disease?
Razafimahatratra S; Guieysse T; Lejeune FX; Houot M; Medani T; Dreyfus G; Klarsfeld A; Villain N; Pereira FR; La Corte V; George N; Pantazis D; Andrade K
Cortex; 2023 Sep; 166():428-440. PubMed ID: 37423786
[TBL] [Abstract][Full Text] [Related]
32. Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.
Quiroz YT; Willment KC; Castrillon G; Muniz M; Lopera F; Budson A; Stern CE
J Alzheimers Dis; 2015; 47(4):955-64. PubMed ID: 26401774
[TBL] [Abstract][Full Text] [Related]
33. The Impact of Awareness of and Concern About Memory Performance on the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Dementia.
Munro CE; Donovan NJ; Amariglio RE; Papp KV; Marshall GA; Rentz DM; Pascual-Leone A; Sperling RA; Locascio JJ; Vannini P
Am J Geriatr Psychiatry; 2018 Aug; 26(8):896-904. PubMed ID: 29866588
[TBL] [Abstract][Full Text] [Related]
34. Measurement of Dimensions of Self-awareness of Memory Function and Their Association With Clinical Progression in Cognitively Normal Older Adults.
Mimmack KJ; Gagliardi GP; Marshall GA; Vannini P;
JAMA Netw Open; 2023 Apr; 6(4):e239964. PubMed ID: 37097631
[TBL] [Abstract][Full Text] [Related]
35. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
36. Cross domain self-monitoring in anosognosia for memory loss in Alzheimer's disease.
Chapman S; Colvin LE; Vuorre M; Cocchini G; Metcalfe J; Huey ED; Cosentino S
Cortex; 2018 Apr; 101():221-233. PubMed ID: 29518705
[TBL] [Abstract][Full Text] [Related]
37. Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial.
Vila-Castelar C; Tariot PN; Sink KM; Clayton D; Langbaum JB; Thomas RG; Chen Y; Su Y; Chen K; Hu N; Giraldo-Chica M; Tobón C; Acosta-Baena N; Luna E; Londoño M; Ospina P; Tirado V; Muñoz C; Henao E; Bocanegra Y; Alvarez S; Rios-Romenets S; Ghisays V; Goradia D; Lee W; Luo J; Malek-Ahmadi MH; Protas HD; Lopera F; Reiman EM; Quiroz YT;
Alzheimers Dement; 2022 Nov; 18(11):2272-2282. PubMed ID: 35103388
[TBL] [Abstract][Full Text] [Related]
38. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
39. Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.
Almkvist O; Larsson M; Graff C
J Alzheimers Dis; 2024; 97(2):587-598. PubMed ID: 38160354
[TBL] [Abstract][Full Text] [Related]
40. Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
Ercoli L; Siddarth P; Huang SC; Miller K; Bookheimer SY; Wright BC; Phelps ME; Small G
Arch Gen Psychiatry; 2006 Apr; 63(4):442-8. PubMed ID: 16585474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
